UNIMEDIC AS

1661 ROLVSØY

Finances

Return on Equity

35,93 %

Current Ratio

1,53

Debt-to-Equity Ratio

0,81

Key figures (NOK)	2022	2021	2020	2019
Revenue	12 591 000	12 611 000	11 643 000	11 681 000
Net Income	3 747 000	2 533 000	1 044 000	1 361 000
Total Assets	22 036 000	16 574 000	15 760 000	17 276 000
Total Equity	10 430 000	7 683 000	6 649 000	6 605 000

Income (NOK)	2022	2021	2020	2019
Revenue	12 591 000	12 611 000	11 643 000	11 681 000
Expenditure	10 503 000	10 251 000	10 354 000	9 896 000
Operating Profit	2 088 000	2 360 000	1 288 000	1 785 000
Financial Income	2 417 000	866 000	463 000	165 000
Financial Costs	355 000	218 000	482 000	240 000
Financial Balance	2 062 000	648 000	−19 000	−75 000
Earnings Before Tax	4 150 000	3 007 000	1 269 000	1 710 000
Tax	402 000	474 000	225 000	348 000
Net Income	3 747 000	2 533 000	1 044 000	1 361 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	17 237 000	13 676 000	13 419 000	14 009 000
Total Current Assets	4 799 000	2 899 000	2 341 000	3 267 000
Total Assets	22 036 000	16 574 000	15 760 000	17 276 000
Total Retained Equity	10 330 000	7 583 000	6 549 000	6 505 000
Total Equity	10 430 000	7 683 000	6 649 000	6 605 000
Total Long-Term Debt	8 461 000	5 389 000	6 806 000	8 192 000
Total Current Debt	3 146 000	3 503 000	2 305 000	2 479 000
Total Equity and Debt	22 036 000	16 574 000	15 760 000	17 276 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	12 376 000	12 470 000	11 537 000	11 369 000
Other Income	215 000	141 000	106 000	312 000
Revenue	12 591 000	12 611 000	11 643 000	11 681 000
Cost of Goods Sold	2 222 000	3 020 000	1 000	119 000
Salary Costs	3 647 000	3 334 000	3 237 000	2 563 000
Depreciation	779 000	1 006 000	981 000	825 000
Impairment	0	0	0	0
Expenditure	10 503 000	10 251 000	10 354 000	9 896 000
Operating Profit	2 088 000	2 360 000	1 288 000	1 785 000
Financial Income	2 417 000	866 000	463 000	165 000
Financial Costs	355 000	218 000	482 000	240 000
Financial Balance	2 062 000	648 000	−19 000	−75 000
Dividends	1 000 000	1 500 000	1 000 000	1 000 000
Net Income	3 747 000	2 533 000	1 044 000	1 361 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	14 091 000	10 942 000	11 327 000	11 728 000
Machinery and Plant Facilities	521 000	686 000	0	0
Fixtures	1 694 000	1 277 000	1 632 000	1 820 000
Total Tangible Assets	16 306 000	12 905 000	12 958 000	13 548 000
Total Fiancial Fixed Assets	931 000	771 000	461 000	461 000
Total Fixed Assets	17 237 000	13 676 000	13 419 000	14 009 000
Stock	0	0	0	0
Total Investments	460 000	460 000	691 000	41 000
Cash, Bank	3 914 000	2 034 000	1 284 000	2 855 000
Total Current Assets	4 799 000	2 899 000	2 341 000	3 267 000
Total Assets	22 036 000	16 574 000	15 760 000	17 276 000
Total Equity	10 430 000	7 683 000	6 649 000	6 605 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	8 461 000	5 389 000	6 806 000	8 192 000
Creditors	184 000	564 000	408 000	454 000
Unpaid Taxes	437 000	458 000	271 000	255 000
Dividends	1 000 000	1 500 000	1 000 000	1 000 000
Other Current Debt	1 107 000	1 284 000	366 000	329 000
Total Current Debt	3 146 000	3 503 000	2 305 000	2 479 000
Total Equity and Debt	22 036 000	16 574 000	15 760 000	17 276 000

Financial indicators	2022	2021	2020	2019
Return on Equity	35,93 %	32,97 %	15,7 %	20,61 %
Debt-to-Equity Ratio	0,81	0,7	1,02	1,24
Operating Profit Margin	16,58 %	18,71 %	11,06 %	15,28 %
Current Ratio	1,53	0,83	1,02	1,32
Quick Ratio	1,53	0,83	1,02	1,32
Equity Ratio	0,47	0,46	0,42	0,38
Gross Profit Margin	82,35 %	76,05 %	99,99 %	98,98 %